Thomas J. Van Rijssen
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Longitudinal polarization diversity optical coherence tomography before and after photodynamic therapy in chronic central serous chorioretinopathy: a prospective clinical study.
Journal: International journal of retina and vitreous
Published: February 13, 2026
Clinical outcomes of pars plana vitrectomy with endoresection in uveal melanoma primarily treated with plaque radiotherapy or proton beam therapy.
Journal: European journal of ophthalmology
Published: December 17, 2025
Bilateral multiple evanescent white dot syndrome in an early adolescent patient: an atypical presentation.
Journal: BMJ case reports
Published: December 03, 2025
Long-Term Follow-Up of PLACE and SPECTRA Trials: Outcomes After Successful and Unsuccessful Half-Dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy.
Journal: American journal of ophthalmology
Published: November 07, 2025
Melanin distribution in a patient with bilateral diffuse uveal melanocytic proliferation utilizing wide-field polarization diversity optical coherence tomography.
Journal: American journal of ophthalmology case reports
Published: October 29, 2025
Evaluating the quantity and spatial density of macrophage-like cells in patients with retinal vascular disease and healthy subjects via non-invasive retinal imaging.
Journal: International journal of retina and vitreous
Published: July 01, 2025
Incidence of Brainstem Anesthesia or Retrobulbar Hemorrhage after Retrobulbar Injection: A Systematic Review and Meta-Analysis.
Journal: Ophthalmology
Published: June 02, 2025
Long-term follow-up of chronic central serous chorioretinopathy patients receiving oral eplerenone and half-dose photodynamic therapy in the SPECTRA trial: SPECTRA trial report No. 4.
Journal: Acta ophthalmologica
Published: May 27, 2025
Outcome and safety of multiple photodynamic therapy sessions in chronic central serous chorioretinopathy.
Journal: Acta ophthalmologica
Published: February 26, 2025
INCREASING EVIDENCE FOR THE SAFETY OF FOVEA-INVOLVING HALF-DOSE PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
Journal: Retina (Philadelphia, Pa.)
Published: February 02, 2023
Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment: SPECTRA trial report No. 3.
Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
Published: June 11, 2022
Crossover to Half-Dose Photodynamic Therapy or Eplerenone in Chronic Central Serous Chorioretinopathy Patients.
Journal: Ophthalmology. Retina
Published: January 07, 2022
Last Updated: 09/26/2026